Have to be careful about getting ahead of your own thinking in this sector. As if I'm one to talk. Anyway, they're doing another lung study and after that is when I believe the data will be collected for the independent review for the peer reviews. I saw someone else mention that the trial would start on the first day that the 4th quarter starts. Really? They need all the data together to build the protocol, which they have a lot, but not all. So the pre IND meeting is still pending, and as far as I know, hasn't yet been requested. That may be in a PR over the next 2 -3 weeks if not sooner.

I'm patient, and I love the volatility. It keeps eyes on the "stock" and potentially brings in strong hands.

I think once the RBL's have what they need they'll be more in tune to allowing IPIX to release more information about the direction they're heading for the trial/s and maybe put the names behind the science.

This is just my thinking, but if the right tumbler clicks into place, IPIX's stage changes over night. And it doesn't have to be grant news, which if it's going the right way would follow shortly.

imo.